Cavendish sees Poolbeg MHRA clearance as key de-risking event with 313% upside to target

Poolbeg Pharma PLC (AIM:POLB, OTC:POLBF, FRA:POLBF) shares rose as much as 8% on Wednesday after receipt of Clinical Trial Authorisation from the UK...